Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion type Assertion NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_head.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion description "[Our findings therefore show that HI-TOPK-032 is a specific inhibitor of TOPK both in vitro and in vivo that may be further developed as a potential therapeutic against colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_provenance.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion evidence source_evidence_literature NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_provenance.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion SIO_000772 22523035 NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_provenance.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion wasDerivedFrom befree-20150227 NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_provenance.
- NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_assertion wasGeneratedBy ECO_0000203 NP921680.RAkYbMbE8vjPVq0TwKAVx5QIQ-7tS9gqSP7Yk4Mahtdr4130_provenance.